GlassScriptPhysician profile
Alecia Folkes
NPI 1811358633
$15,602.29
in general payments reported to CMS, 2019-2025
33 companies · $2,666 in 2025
The $2,666 reported for 2025 was more than what 82% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,405 · 2020: $1,229 · 2021: $771 · 2022: $847 · 2023: $5,063 · 2024: $2,621 · 2025: $2,666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,006 · Consulting Fee: $2,800 · Education: $479 · Travel and Lodging: $65.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,005.51 |
| Consulting Fee | $2,800.00 |
| Education | $478.97 |
| Travel and Lodging | $65.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $3,410.47 | 2019-2024 | Ilumya, Blu-U, Odomzo |
| Janssen Biotech, INC. | $1,941.53 | 2019-2025 | Tremfya |
| Abbvie INC. | $1,894.62 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,217.12 | 2019-2025 | Dupixent |
| Galderma Laboratories, L.P. | $860.14 | 2022-2025 | Nemluvio, Aklief, Oracea |
| Dermavant Sciences, INC. | $840.31 | 2023-2024 | Vtama |
| Lilly USA, LLC | $660.39 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Novartis Pharmaceuticals Corporation | $652.66 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $610.36 | 2019-2020 | |
| Pfizer INC. | $555.94 | 2019-2025 | |
| Genzyme Corporation | $532.23 | 2019-2025 | |
| Amgen INC. | $443.79 | 2019-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $323.58 | 2024-2025 | Sotyktu |
| Incyte Corporation | $314.11 | 2021-2025 | Opzelura |
| Ucb, INC. | $245.34 | 2019-2024 | Bimzelx, Cimzia |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $161.11 | 2019-2023 | Jublia, Arazlo |
| Leo Pharma INC. | $132.44 | 2020-2025 | Adbry |
| Arcutis Biotherapeutics, INC. | $114.83 | 2023-2025 | Zoryve |
| Vyne Pharmaceuticals INC. | $112.51 | 2020-2021 | |
| Almirall LLC | $108.16 | 2023-2025 | Klisyri, Seysara |
| Celgene Corporation | $87.45 | 2019 | |
| Sanofi-Aventis U.S. LLC | $69.99 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.61 | 2024-2025 | Spevigo |
| Biofrontera INC. | $44.33 | 2019-2024 | Rhodoled Xl, Ameluz, Xepi |
| Verrica Pharmaceuticals INC. | $32.05 | 2023 | Ycanth |
| Smith+Nephew, INC. | $31.97 | 2023 | Grafix |
| Mayne Pharma Commercial LLC | $30.92 | 2023 | |
| Kyowa Kirin, INC. | $28.48 | 2021 | |
| Acera Surgical, INC. | $25.31 | 2023 | Restrata Wound Matrix |
| Journey Medical Corporation | $21.92 | 2023 | |
| Botanix Sb INC | $17.44 | 2025 | Sofdra |
| Strata Skin Sciences, INC. | $15.56 | 2022 | |
| Organon LLC | $12.62 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alecia Folkes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.